Table 5.
Anticipated benefits and recognized limitations of electronic tracking device (ETD) use (N=29).
|
|
Companies, n (%)a | |||
| Anticipated benefits | ||||
|
|
Persons with dementia | |||
|
|
|
Increase safety | 23 (79) | |
|
|
|
Maintain or increase independence | 11 (38) | |
|
|
|
Improve psychological or emotional state | 9 (31) | |
|
|
Caregivers | |||
|
|
|
Increase peace of mind | 21 (72) | |
|
|
|
Increase knowledge | 9 (31) | |
|
|
|
Enable higher-quality care | 7 (24) | |
|
|
|
Increase caregiver independence | 4 (14) | |
|
|
Both persons with dementia and caregivers | |||
|
|
|
ETD is affordable and cost-effective | 6 (21) | |
|
|
|
Improve interpersonal relationship | 3 (10) | |
| Recognized limitations of ETDs | ||||
|
|
Technical limitations | 7 (24) | ||
|
|
Role and fit limitations | 6 (21) | ||
|
|
Price limitations | 6 (21) | ||
|
|
Ethical limitations | 4 (14) | ||
aThe companies may appear in multiple categories.